These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [Deep venous thrombosis in an adolescent taking oral contraceptives]. de Tournemire R; Maugas AC Arch Pediatr; 2002 Aug; 9(8):873-4. PubMed ID: 12205799 [No Abstract] [Full Text] [Related]
9. What is the risk of venous thromboembolism (VTE) among women taking third-generation oral contraceptives (OCs) in comparison with those taking contraceptives containing levonorgestrel? Meurer LN; Slawson JG J Fam Pract; 2001 Feb; 50(2):108. PubMed ID: 11219554 [No Abstract] [Full Text] [Related]
10. Risk factors for heart attack, stroke, and venous thrombosis associated with hormonal contraceptive use. Zakharova MY; Meyer RM; Brandy KR; Datta YH; Joseph MS; Schreiner PJ; Rao GH; Divani AA Clin Appl Thromb Hemost; 2011 Aug; 17(4):323-31. PubMed ID: 20530058 [TBL] [Abstract][Full Text] [Related]
12. [Complications of hormonal contraception. 38th Congress of the "Zurich Discussion Group", April 2007]. Birkhäuser M; Braendle W; Keller PJ; Kiesel L; Kuhl H; Neulen J Gynakol Geburtshilfliche Rundsch; 2009; 49(1):39-44. PubMed ID: 19204401 [No Abstract] [Full Text] [Related]
13. UK high court dismisses risk of VTE in "pill" test case. Ashraf H Lancet; 2002 Aug; 360(9330):391. PubMed ID: 12241785 [No Abstract] [Full Text] [Related]
14. The effect of different hormonal contraceptives on plasma levels of free protein S and free TFPI. Thromb Haemost; ; . PubMed ID: 23407778 [TBL] [Abstract][Full Text] [Related]